
NASDAQ:TLRY
This summary was created by AI, based on 3 opinions in the last 12 months.
Tilray Inc. (TLRY-Q) has recently faced some challenging financial metrics, with reported revenues experiencing notable declines. In the latest quarter, the company saw a revenue of $288 million, reflecting a -6.6% drop from the previous quarter, while gross profit decreased by 14.9%, totaling $79 million. Another report highlighted an even steeper revenue decline, with figures falling to $210 million, a -32% change. This decline in both revenue and gross profit raises concerns regarding demand for Tilray's products and potentially indicates market challenges. Despite these issues, social media mentions have surged by over 28% in the last day, suggesting a rising interest that may not yet be reflected in financial performance. Investors are advised to look towards the U.S. market for potentially better opportunities and to consider using their current holdings for tax loss purposes.
A lot of $$ was made, but now investors have come to realize marijuana is just a commodity. The company bears all the costs, but it has the federal/provincial government as a partner that shares equally in all the upside, but none of the down. Even advertising is restricted.
For a consumer stock, he holds Unilever.
So much wealth got destroyed in the cannabis sector, but Tilray will be one of the survivors. He can't offer a solid opinion about TLRY, because he needs to learn more about it, but he's starting to study the cannabis sector. Something will happen in the U.S. that will make banking for these companies allowable--and this will be a major move.
Tilray Inc. is a American stock, trading under the symbol TLRY (previously TLRY-Q on Stockchase) on the NASDAQ (TLRY). It is usually referred to as NASDAQ:TLRY or TLRY
In the last year, 1 stock analyst published opinions about TLRY (previously TLRY-Q on Stockchase). 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Tilray Inc..
Tilray Inc. was recommended as a Top Pick by Jim Cramer - Mad Money on 2022-09-30. Read the latest stock experts ratings for Tilray Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Tilray Inc. in the last year. It is a trending stock that is worth watching.
On 2026-06-04, Tilray Inc. (TLRY) stock closed at a price of $5.23.
Even with talk of rescheduling cannabis, US names offer significantly more upside than Canadian names. Look to the US if you want to take on this risk. If you own this one, use it as a tax loss.